Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine.
Arlt
Sönke
S
Cepek
Lukas
L
Rustenbeck
Hans Heino
HH
Prange
Hilmar
H
Reimers
Carl Detlev
CD
D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D003072:Cognition Disorders / Q000139:chemically induced / Q000503:physiopathology; D003287:Contrast Media / Q000506:poisoning*; D004305:Dose-Response Relationship, Drug; D062787:Drug Overdose / Q000473:pathology / Q000503:physiopathology; D005682:Gadolinium / Q000506:poisoning*; D019786:Gadolinium DTPA / Q000506:poisoning*; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D007278:Injections, Spinal / Q000009:adverse effects / Q000592:standards; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009192:Myelography / Q000009:adverse effects; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D013346:Subarachnoid Space / Q000187:drug effects / Q000503:physiopathology; D013995:Time; D014057:Tomography, X-Ray Computed / Q000009:adverse effects
D003287:Contrast Media; D005682:Gadolinium; D019786:Gadolinium DTPA